Allan Tillack has taken on the
role of Chair of the newly renamed
Generic and Biosimilar Medicines
Association (GBMA) with the
appointment effective immediately.
Tillack is Australia/NZ head
of Sandoz, with his extensive
career also including roles with
Alphapharm, Astra, Monsanto and
Abbott Nutrition.
He was formerly GMiA deputy
chair working with outgoing chair
Mark Crotty to secure the recently
signed Strategic Agreement with the
government “and deliver a five year
period of certainty” for the generic
and biosimilar medicines industry.The above article was sent to subscribers in Pharmacy Daily's issue from 03 Aug 15 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 03 Aug 15
IN WESTERN Australia, Michael’s Chemist Group has started stocking therapeutic Nicotine Vaping Products (NVPs), pursuant to the Federal Government’s new vaping laws (PD 25 Mar).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.